118 (PB106): Discovery and pre-clinical development of AKY-1189, a potent and selective Nectin-4 miniprotein binder optimized for use as a targeted radiopharmaceutical

118 (PB106): Discovery and pre-clinical development of AKY-1189, a potent and selective Nectin-4 miniprotein binder optimized for use as a targeted radiopharmaceutical

Saved in:
Bibliographic Details
Published in:European journal of cancer (1990) Vol. 211; p. 114641
Main Authors: Way, J., Iii, W. Blackwell, Clay, A., Copeland, M., Doligalski, M.L., Gober, I., Kil, H.J., Kosciuk, T., Lipovšek, D., Lau, W., Makvandi, M., Paulus, I., Price, T., Sauls, H., Subramanian, S., Swiger, E., Woodward, M., Kovacs, J., Feldman, P.
Format: Journal Article
Language:English
Published: Elsevier Ltd 01-10-2024
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0959-8049
DOI:10.1016/j.ejca.2024.114641